Medreich Limited — Ezetimibe Exporter Profile
Indian Pharmaceutical Exporter · #5 for Ezetimibe · $12.4M export value · DGFT Verified
Medreich Limited is the #5 Indian exporter of Ezetimibe with $12.4M in export value and 406 verified shipments. Medreich Limited holds a 2.4% market share in Ezetimibe exports across 9 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.
Medreich Limited — Ezetimibe Export Profile: Buyers & Destinations
Where Does Medreich Limited Export Ezetimibe?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NETHERLANDS | $10.6M | 366 | 97.1% |
| PHILIPPINES | $103.5K | 11 | 0.9% |
| SINGAPORE | $74.4K | 13 | 0.7% |
| INDONESIA | $66.6K | 6 | 0.6% |
| UNITED KINGDOM | $42.4K | 1 | 0.4% |
| THAILAND | $32.6K | 2 | 0.3% |
| MALTA | $5 | 2 | 0.0% |
| RUSSIA | $0 | 1 | 0.0% |
| FRANCE | $0 | 4 | 0.0% |
Medreich Limited exports Ezetimibe to 9 countries. The largest destination is NETHERLANDS accounting for 97.1% of Medreich Limited's Ezetimibe shipments, followed by PHILIPPINES (0.9%) and SINGAPORE (0.7%). These destinations reflect Medreich Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ezetimibe from Medreich Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| BGP PRODUCTS GMBH | NETHERLANDS | $10.6M | 366 |
| ABBOTT LABORATORIES | PHILIPPINES | $81.3K | 10 |
| PT MEIJI INDONESIA | INDONESIA | $66.6K | 6 |
| ABBOT LABORATORIES PTE LTD | SINGAPORE | $46.1K | 8 |
| MEDREICH PLC | UNITED KINGDOM | $42.4K | 1 |
| ABBOTT LABORATORIES LIMITED | THAILAND | $32.6K | 2 |
| ABBOT LABORATORIES PTE LIMITED | SINGAPORE | $28.3K | 5 |
| ABBOTT LABORATORIES VENICE CORPORATE CENTERNUMBER | PHILIPPINES | $22.2K | 1 |
| PHARMADOX HEALTHCARE LIMITED | MALTA | $5 | 2 |
| ABBOTT LABORATORIES LLC | RUSSIA | $0 | 1 |
Medreich Limited supplies Ezetimibe to 11 buyers globally. The largest buyer is BGP PRODUCTS GMBH (NETHERLANDS), followed by ABBOTT LABORATORIES (PHILIPPINES) and PT MEIJI INDONESIA (INDONESIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ezetimibe Export Value and How Much Does Medreich Limited Contribute?
India exported $106.2M worth of Ezetimibe through 5,033 shipments from 169 suppliers to 85 countries, serving 466 buyers globally. Medreich Limited contributes $12.4M to this total, accounting for 2.4% of India's Ezetimibe exports. Medreich Limited ships Ezetimibe to 9 countries through 11 buyers.
What Is the Average Shipment Value for Medreich Limited's Ezetimibe Exports?
Medreich Limited's average Ezetimibe shipment value is $30.5K per consignment, based on 406 shipments totaling $12.4M. The largest destination is NETHERLANDS (97.1% of Medreich Limited's Ezetimibe exports).
How Does Medreich Limited Compare to Other Indian Ezetimibe Exporters?
Medreich Limited ranks #5 among 169 Indian Ezetimibe exporters with a 2.4% market share. The top 3 exporters are ALKEM LABORATORIES LIMITED ($19.4M), INTAS PHARMACEUTICALS LIMITED ($16.6M), PIRAMAL PHARMA LIMITED ($13.4M). Medreich Limited processed 406 shipments to 9 destination countries.
What Ezetimibe Formulations Does Medreich Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ROSUVASTATIN 10MG AND EZETIMIBE 10MG TAB | $1.4M | 47 |
| ROSUVASTATIN 20MG AND EZETIMIBE 10MG TAB | $1.3M | 36 |
| ROSUVASTATIN 10MG AND EZETIMIBE 10MG TABLETS TWICOR 10MG/10MGVIATRIS/FRANCE PACK SIZE:9X10S QTY:10420 | $142.0K | 3 |
| ROSUVASTATIN 20MG AND EZETIMIBE 10MG TABLETS (TWICOR 20MG/10MG) MYLAN/SPAIN ( PACK SIZE 3X10S ) ( 62852 PACKS )NOS | $116.3K | 3 |
| ROSUVASTATIN 20MG AND EZETIMIBE 10MG TABLETS (ATEROGER 20MG/10MG)MYLAN/SPAIN PACK SIZE:3X10S QTY:62352NOS | $115.6K | 3 |
| ROSUVASTATIN 20MG AND EZETIMIBE 10MG TABLETS (TWICOR 20MG/10MG) MYLAN/SPAIN. ( PACK SIZE 3X10S ) ( 62052 PACKS )NOS | $114.8K | 3 |
| ROSUVASTATIN 20MG AND EZETIMIBE 10MG TABLETS (TWICOR 20MG/10MG) MYLAN/SPAIN ( PACK SIZE 3X10S ) (62880 PACKS ) | $112.6K | 3 |
| ROSUVASTATIN 20MG AND EZETIMIBE 10MG TABLETS (TWICOR 20MG/10MG) ( PACK SIZE 3X10S ) ( 62760 PACKS ) | $112.3K | 3 |
| ROSUVASTATIN 20MG AND EZETIMIBE 10MG TABLETS (TWICOR 20/10MG) ( PACK SIZE 9X10S) ( 20980 PACKS ) | $109.9K | 3 |
| ROSUVASTATIN 20MG AND EZETIMIBE 10MG TABLETS MYROSOR 20MG/10MG TABLETSMYLAN/BELGIUM PACK SIZE:9X10S QTY:10268 | $100.0K | 2 |
Medreich Limited exports 229 distinct Ezetimibe formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ROSUVASTATIN 10MG AND EZETIMIBE 10MG TAB with 47 shipments worth $1.4M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Medreich Limited Compare to Nearest Ezetimibe Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | INTAS PHARMACEUTICALS LIMITED | $16.6M | 333 | 17 | $50.0K |
| 1 | PIRAMAL PHARMA LIMITED | $13.4M | 269 | 3 | $50.0K |
| 5 | MEDREICH LIMITED ★ | $12.4M | 406 | 9 | $30.5K |
| 4 | MYLAN LABORATORIES LIMITED | $12.3M | 246 | 6 | $50.0K |
| 6 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $7.9M | 191 | 10 | $41.3K |
Medreich Limited ranks #5 among 169 Indian Ezetimibe exporters. Average shipment value of $30.5K compared to the market average of $628.6K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and PIRAMAL PHARMA LIMITED.
Which Indian Ports Ship Ezetimibe Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 814 | 16.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 663 | 13.2% |
| DELHI AIR CARGO ACC (INDEL4) | 515 | 10.2% |
| DELHI AIR | 369 | 7.3% |
| NHAVA SHEVA SEA (INNSA1) | 235 | 4.7% |
| Bombay Air | 164 | 3.3% |
| BANGALORE AIR | 152 | 3.0% |
| MUNDRA SEA | 150 | 3.0% |
Geopolitical & Trade Policy Impact on Medreich Limited's Ezetimibe Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)
Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)
The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)
Medreich Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)
For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.
About Medreich Limited
Medreich Limited exports 42 products worth $224.8M. Beyond Ezetimibe, top products include Amoxicillin, Potassium, Flucloxacillin, Rosuvastatin, Atorvastatin. View the complete Medreich Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ezetimibe — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ezetimibe shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medreich Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 406 individual customs records matching Medreich Limited exporting Ezetimibe, covering 229 formulations to 9 countries via 11 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 85+ countries, 466+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ezetimibe Export Data from Medreich Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medreich Limited's Ezetimibe exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medreich Limited
Full Company Profile →
42 products · $224.8M total trade · 15 categories
Ezetimibe Stats
Company Overview
Top Products by Medreich Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medreich Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ezetimibe. For current shipment-level data, contact TransData Nexus.